Quest Diagnostics Incorporated (DGX) is currently Overvalued by 33.68%

Quest Diagnostics Incorporated (DGX) appears overvalued by approximately 33.68% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Downside (live) 33.68% (from live valuation API)
Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$213.45

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Quest Diagnostics Incorporated overvalued or undervalued?

For Quest Diagnostics Incorporated, intrinsic value ties fair value to sustainable cash generation; with the stock below that level, the snapshot reads as a discount versus fundamentals rather than a pure sentiment call.

Historical valuation for DGX shows cycles where multiples expanded and compressed; today’s positioning rhymes more with defensive pricing than the mid-range of its recent history.

Market expectations boil down to growth, risk, and return on capital—current levels leave more room for upside if execution is steady. Cross-check with live ratios when your API is connected.

Key metrics

P/E ratio: 46.1x
Revenue growth (TTM y/y): 15%
Profit margin: 9.7%
Fair value (model): Unlock

Next steps

Frequently asked questions — DGX

Is DGX overvalued right now?

Based on our 2026 models, Quest Diagnostics Incorporated (DGX) appears overvalued at $213.45 with roughly 33.7% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is Quest Diagnostics Incorporated's intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether DGX trades above or below fair value. At $213.45, Quest Diagnostics Incorporated currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Quest Diagnostics Incorporated's intrinsic value calculated?

Tickerplace calculates DGX's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is DGX undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether DGX's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for DGX: open their overvalued / undervalued view.

Instant valuation answer